12/20/2024 2:17 PM | V-CO Investors LLC (Filed by) Vivos Therapeutics (Subject)
| Form SCHEDULE 13G | |
11/27/2024 4:25 PM | Vivos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2024 3:43 PM | Amman Bradford K. (Reporting) Vivos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2024 3:47 PM | Huntsman Ronald Kirk (Reporting) Vivos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2024 1:59 PM | Ionic Ventures, LLC (Filed by) Vivos Therapeutics (Subject)
| Form SC 13G | |
09/20/2024 7:00 AM | Vivos Therapeutics (Filer)
| Form 424B5 | |
09/20/2024 7:05 AM | Vivos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
09/18/2024 7:00 AM | Vivos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 4:00 PM | Vivos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 3:24 PM | Vivos Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 4:19 PM | Vivos Therapeutics (Filer)
| Form 424B1 | |
08/07/2024 11:15 PM | Vivos Therapeutics (Filer)
| Form EFFECT | |
07/29/2024 8:06 PM | Vivos Therapeutics (Filer)
| Form 10-K/A | |
07/30/2024 5:17 AM | Vivos Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
07/10/2024 7:00 AM | Vivos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2024 7:53 PM | Amman Bradford K. (Reporting) Vivos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 7:53 PM | Lindsay Mark F. (Reporting) Vivos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 7:53 PM | Krammer Anja B (Reporting) Vivos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 7:53 PM | Green Ralph Elias (Reporting) Vivos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 7:53 PM | Thompson Matthew (Reporting) Vivos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 7:53 PM | SOKOLOW LEONARD J (Reporting) Vivos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 7:53 PM | Huntsman Ronald Kirk (Reporting) Vivos Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:30 PM | Vivos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2024 1:54 PM | Vivos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 3:16 PM | Vivos Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/28/2024 11:15 PM | Vivos Therapeutics (Filer)
| Form EFFECT | |
04/19/2024 6:52 PM | Vivos Therapeutics (Filer)
| Form S-1/A | |
04/08/2024 7:22 PM | Vivos Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
03/28/2024 7:38 PM | Vivos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/15/2024 7:55 AM | Vivos Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 4:42 PM | Huntsman Ronald Kirk (Filed by) Vivos Therapeutics (Subject) Vivos Therapeutics (Subject)
| Form SC 13G/A | |